| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Stopnja umrljivosti po transkatetrski zamenjavi aorte zaklopke v primerjavi s kirurško zamenjavo aorte zaklopke
Authors:ID Bračko, Lucijan (Author)
ID Koželj, Anton (Mentor) More about this mentor... New window
ID Gosak, Lucija (Comentor)
Files:.pdf VS_Bracko_Lucijan_2025.pdf (952,40 KB)
MD5: 078B7BF715A0DB602B0C8F31E1554E69
 
Language:Slovenian
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:FZV - Faculty of Health Sciences
Abstract:Uvod: Aortna stenoza (AS) je najpogostejši vzrok srčnega popuščanja v razvitih državah. Incidenca aortne stenoze s starostjo narašča in prizadene približno 10 % prebivalstva. Tradicionalno se AS zdravi s kirurško zamenjavo aortne zaklopke (SAVR), v zadnjih časih pa se vse več uporablja transkatetrska zamenjava aortne zaklopke (TAVR). Metode: V zaključnem delu smo sistematično pregledali in analizirali znanstveno literaturo. Literaturo smo iskali v mednarodnih podatkovnih bazah PubMed, CINAHL Ultimate in ScienceDirect. Postopek iskanja literature smo prikazali s PRISMA-diagramom, rezultate smo prikazali z evalvacijsko in s sintezno tabelo. Rezultati: V končno analizo smo vključili 15 raziskav. Rezultati so pokazali manjšo stopnjo umrljivosti po TAVR in višjo po SAVR. Slabosti SAVR posega so večje krvavitve, na novo nastala atrijska fibrilacija in akutne poškodbe ledvic. Slabosti TAVR so potreba po vsaditvi trajnega srčnega spodbujevalnika, aortna regurgitacija in žilni zapleti. Razprava in zaključek: Za odločitev TAVR ali SAVR-poseg je potrebna celovita klinična ocena pacienta in sodelovanje kardiološkega tima za optimalno izveden poseg, ki omogoči pacientu kvalitetno življenje. Z napredkom tehnologije bo TAVR predstavljal večkrat izbrano alternativo SAVR-posegu.
Keywords:aortna stenoza, TAVR, SAVR, stopnja umrljivosti
Place of publishing:Maribor
Publisher:[L. Bračko]
Year of publishing:2025
PID:20.500.12556/DKUM-92636 New window
UDC:616.132-089+616-036.8(043.2)
COBISS.SI-ID:241132803 New window
Publication date in DKUM:20.08.2025
Views:242
Downloads:21
Metadata:XML DC-XML DC-RDF
Categories:FZV
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:25.04.2025

Secondary language

Language:English
Title:Mortality rate after transcatheter aortic valve replacement compared with surgical aortic valve replacement
Abstract:Abstract Introduction: Aortic stenosis (AS) is the most common cause of heart failure in the developed world. The incidence of AS increases with age and affects approximately 10% of the population. Traditionally, AS has been treated by surgical aortic valve replacement (SAVR), but more recently transcatheter aortic valve replacement (TAVR) has been increasingly used. Methods: The literature was searched using the international databases PubMed, CINAHL Ultimate and ScienceDirect. A PRISMA diagram was used to present the literature search process, and the results were presented in an appraisal and synthesis table. Results: The results showed a lower mortality rate after TAVR and a higher mortality rate after SAVR. The disadvantages of SAVR are major bleeding, new-onset atrial fibrillation, and acute kidney injury. The disadvantages of TAVR are the need for permanent pacemaker implantation, aortic regurgitation, and vascular complications. Discussion and conclusion: The decision to perform TAVR or SAVR requires a comprehensive clinical assessment of the patient and collaboration with the cardiology team to optimise the procedure to provide a good quality of life for the patient. As technology advances, TAVR will become the alternative of choice to SAVR.
Keywords:aortic stenosis, TAVR, SAVR, mortality rate


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica